Understand the source comparison
Tesofensine Help Serotonin Research: Comparison Table
This table compares tesofensine to selective serotonin agents across key dimensions relevant to neurochemical research. | Feature | Tesofensine | SSRIs (e.g., Fluoxetine) | SNRIs (e.g., Venlafaxine) | Professional Assessment ||—|—|—|—|| Serotonin Transporter I
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- This table compares tesofensine to selective serotonin agents across key dimensions relevant to neurochemical research.
- | Feature | Tesofensine | SSRIs (e.g., Fluoxetine) | SNRIs (e.g., Venlafaxine) | Professional Assessment ||—|—|—|—|| Serotonin Transporter Inhibition (SERT IC50) | 6.5 nM. Moderate potency | 1–10 nM depending on agent. High selectivity | 82 nM (venlafaxine). Weaker SERT inhibition than SSRIs | Tesofensine's SERT inhibition is pharmacologically relevant but not dominant. Allows serotonin elevation in the presence of elevated catecholamines || Dopamine Transporter Inhibition (DAT IC50) | 1.8 nM. Strongest of the three targets | None. SSRIs do not bind DAT | None. SNRIs spare dopamine | Tesofensine is the only compound in this comparison that directly elevates dopamine, making it uniquely suited for reward-serotonin interaction studies || Norepinephrine Transporter Inhibition (NET IC50) | 2.5 nM. High potency | None. Pure SSRIs spare norepinephrine | 2480 nM (venlafaxine immediate-release). Moderate NET inhibition at higher doses | Tesofensine produces stronger norepinephrine elevation th